-
Vaccines, Blood & Biologics
-
Resources for You
-
-
Blood Research
-
Cellular Hematology
- Studies on Safety and Efficacy of Platelets and Other Transfused Blood Products
Jaroslav Vostal, MD - Blood Safety: Infectious Agent Interventions and Development of Storage Biomarkers for Blood Cells and Related Products
C.D. Atreya, PhD - Blood and Vascular Biocompatibility of Biologic and Engineered Micro/Nanoparticles: The Role of Cell Membrane Microparticles in Adverse Events and as Biomarkers
Jan Simak, PhD
-
-
Plasma Derivatives
- Safety and Efficacy of Immune Globulins and Alpha-1 Proteinase Inhibitors
Dorothy Scott, MD - Studies on the Safety and Efficacy of Plasma-derived Products and their Recombinant Analogs
Basil Golding, MD - Safety and Efficacy of Plasma-derived Products
Mei-Ying W. Yu, PhD - Evaluation and Characterization of Neutralizing Antibodies against Viruses Relevant to Blood-Derived Products
Pei Zhang, PhD
-
-
Hemostasis
-
-
Biochemistry & Vascular Biology
- Evaluating the Safety and Efficacy of Hemoglobin-based Blood Substitutes
Abdu I. Alayash, PhD - Vascular Responses and Biological Product Safety and Efficacy
Felice D'Agnillo, PhD
-
-
Molecular Virology
- Improving Safety of the Blood Supply from Transmission of HIV/AIDS and Other Emerging Retroviral, Blood Borne Viral and Biodefense Agents by Development of Sensitive Diagnostic Tools and Investigations of Disease Pathogenesis
Indira Hewlett, PhD - Studies on a Potential Vaccine for the Treatment of HIV Infection and Sensitive Immunoassays to Simultaneously Detect Multiple Infections and Monitor Post-vaccination Safety
Subhash Dhawan, PhD - HIV Infections and the Safety of the Blood Supply
Andrew I. Dayton, MD, PhD - Improving the Safety of the Blood Supply from West Nile Virus (WNV) Infection by the Development and Evaluation of Diagnostic Tools for Blood Donor Screening
Maria Rios, PhD
-
-
Hepatitis & Related Emerging Agents
-
-
Bacterial, Parasitic & Unconventional Agents
- Medical Product Purity: Maintaining Biologics and Other FDA-regulated Products Free of the Infectious Agents of Transmissible Spongiform Encephalopathies (TSE Agents or Prions)
David M. Asher, PhD - Improving the Safety of Blood and Blood Related Products by Reducing the Risk of Transfusion-Transmission of Leishmania Parasites
Hira Nakhasi, PhD - Safety of Blood and Blood Products from Contamination with Malaria Parasites and Studies on Malaria Immunity and Pathogenesis
Sanjai Kumar, PhD - Studies to Evaluate Blood Safety: Risk of Transmission of Parasites such as Trypanosoma cruzi through Blood Transfusion
Alain Debrabant, PhD - Pathogenesis of Transmissible Spongiform Encephalopathies
Pedro Piccardo, MD
-
Contact Us
- (800) 835-4709
- (301) 827-1800
- ocod@fda.hhs.gov
Consumer Affairs Branch (CBER)
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-
-